Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancerP Lissoni, E Tisi, S Barni, et al.
Tumori|June 30, 1987
Correlation between changes in prolactin and melatonin serum levels after radical mastectomyP Lissoni, F Paolorossi, S Barni, et al.
Cancer|August 1, 1988
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerationsD Esposti, P Lissoni, G Tancini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[Immunotherapy with low-dose subcutaneous interleukin-2 in metastatic renal carcinoma]P Lissoni, S Barni, G Tancini, et al.
British Journal of Cancer|January 1, 1994
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanomaP Lissoni, S Barni, G Tancini, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
British Journal of Cancer|June 1, 1993
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tractP Lissoni, S Barni, G Tancini, et al.
La Radiologia Medica|November 1, 1990
[Radiotherapy plus a combination of cisplatin and 5-fluorouracil for locally advanced head and neck neoplasms. Study of feasibility and preliminary results]A Colombo, S Crispino, G Tancini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1995
[Prognostic predictive factors of the clinical response to immunotherapy with subcutaneous interleukin-2, in patients with metastatic renal carcinoma: analysis of 60 cases]P Lissoni, E Scardino, P Favini, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancerP Lissoni, E Tisi, S Barni, et al.
Tumori|June 30, 1987
Correlation between changes in prolactin and melatonin serum levels after radical mastectomyP Lissoni, F Paolorossi, S Barni, et al.
Cancer|August 1, 1988
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerationsD Esposti, P Lissoni, G Tancini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1993
[Immunotherapy with low-dose subcutaneous interleukin-2 in metastatic renal carcinoma]P Lissoni, S Barni, G Tancini, et al.
British Journal of Cancer|January 1, 1994
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanomaP Lissoni, S Barni, G Tancini, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
British Journal of Cancer|June 1, 1993
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tractP Lissoni, S Barni, G Tancini, et al.
La Radiologia Medica|November 1, 1990
[Radiotherapy plus a combination of cisplatin and 5-fluorouracil for locally advanced head and neck neoplasms. Study of feasibility and preliminary results]A Colombo, S Crispino, G Tancini, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1995
[Prognostic predictive factors of the clinical response to immunotherapy with subcutaneous interleukin-2, in patients with metastatic renal carcinoma: analysis of 60 cases]P Lissoni, E Scardino, P Favini, et al.
Pageof 37